EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Randomisierte kontrollierte StudieMultizentrische Studie

Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled Trial

Vedang Murthy, Priyamvada Maitre, Ganesh Bakshi, Mahendra Pal, Maneesh Singh, Rakesh Sharma, Duleep Gudipudi, Lincoln Pujari, Himanshu Pandey, Bhavesh Bandekar, Deepa Joseph, Rahul Krishnatry und 9 weitere

International Journal of Radiation Oncology*Biology*Physics · 2025

DOI: 10.1016/j.ijrobp.2024.09.040 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Vedang Murthy und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Electronic address: vmurthy@actrec.gov.in. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Carcinoma, Transitional Cell. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Tata Memorial Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To report toxicity from the multicenter phase III randomized trial of Bladder Adjuvant Radiation Therapy (BART) after radical cystectomy and chemotherapy in high-risk muscle-invasive bladder cancer (MIBC). METHODS AND MATERIALS: Patients with nonmetastatic urothelial MIBC with ≥1 high-risk feature after radical cystectomy- pT3-4, pN1-3, nodal yield

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCarcinoma, Transitional CellHumansMaleFemaleAgedMiddle AgedRadiotherapy, AdjuvantCystectomyRadiotherapy, Intensity-ModulatedChemotherapy, AdjuvantRadiation InjuriesNeoadjuvant TherapyRadiotherapy, Image-GuidedAged, 80 and overAdultCisplatin

Substanzen

Cisplatin

Autor:innen und Institutionen

  • Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Electronic address: vmurthy@actrec.gov.in.
  • Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Division of Uro-oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Department of Surgery, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, India.
  • Department of Surgery, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, India; Department of Radiation Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderaba…
  • Department of Radiation Oncology, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Varanasi, India.

Förderung

  • Tata Memorial Centre

Zitieren

APA

Murthy, V., Maitre, P., Bakshi, G., Pal, M., Singh, M., Sharma, R., Gudipudi, D., Pujari, L., Pandey, H., Bandekar, B., Joseph, D., Krishnatry, R., Phurailatpam, R., Kannan, S., Arora, A., Misra, A., Joshi, A., Noronha, V., Prabhash, K., …, & Prakash, G. (2025). Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled Trial. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2024.09.040

Vancouver

Murthy V, Maitre P, Bakshi G, Pal M, Singh M, Sharma R, et al. Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled Trial. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2024.09.040

BibTeX
@article{Murthy2025,
  author = {Murthy, Vedang and Maitre, Priyamvada and Bakshi, Ganesh and Pal, Mahendra and Singh, Maneesh and Sharma, Rakesh and Gudipudi, Duleep and Pujari, Lincoln and Pandey, Himanshu and Bandekar, Bhavesh and Joseph, Deepa and Krishnatry, Rahul and Phurailatpam, Reena and Kannan, Sadhana and Arora, Amandeep and Misra, Ankit and Joshi, Amit and Noronha, Vanita and Prabhash, Kumar and Menon, Santosh and Prakash, Gagan},
  title = {Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled Trial},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2025},
  doi = {10.1016/j.ijrobp.2024.09.040}
}
Kostenlos starten →